BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10473510)

  • 1. Clinical utility of testing for antineutrophil cytoplasmic antibodies.
    Vassilopoulos D; Hoffman GS
    Clin Diagn Lab Immunol; 1999 Sep; 6(5):645-51. PubMed ID: 10473510
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cocaine, ANCA, and Wegener's granulomatosis].
    Morassi ML; Trimarchi M; Nicolai P; Gregorini G; Maroldi R; Specks U; Facchetti F
    Pathologica; 2001 Oct; 93(5):581-3. PubMed ID: 11725361
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison between enzyme-linked immunosorbent assay and indirect immunofluorescence for detection of antineutrophil cytoplasmic antibodies.
    Menezes JM; Rossener R; Silva APMAD; Rodrigues SS; Mangueira CLP
    Einstein (Sao Paulo); 2020; 18():eAO5132. PubMed ID: 31994608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of antineutrophil cytoplasmic antibodies.
    Rus V; Handwerger BS
    Curr Rheumatol Rep; 2000 Oct; 2(5):383-9. PubMed ID: 11123087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of autoantibodies in systemic autoimmune diseases: clinically useful?
    Kallenberg CG; Stegeman CA; Bootsma H; Bijl M; Limburg PC
    Lupus; 2006; 15(7):397-402. PubMed ID: 16898172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases.
    Vizjak A; Nagode B; Rott T; Koselj M; Rozman B; Kaplan-Pavlovcic S; Kosnik M; Petric V; Ferluga D
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):665-70. PubMed ID: 11020953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical applications of antineutrophil cytoplasmic antibody testing.
    Schmitt WH; van der Woude FJ
    Curr Opin Rheumatol; 2004 Jan; 16(1):9-17. PubMed ID: 14673383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antineutrophil cytoplasmic antibodies and associated diseases].
    Sghiri R; Meddeb H; Bouguila J; Jarray M; Bahri F; Nouira R; Zellama D; Achour A; Essoussi AS; Harbi A; Ghedira I
    Pathol Biol (Paris); 2009 Jul; 57(5):398-402. PubMed ID: 18834675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe acquired neutropenia associated with anti-proteinase 3 antibodies.
    Loschi M; Jouen F; Kerleau JM; Tilly H; Jardin F
    Acta Haematol; 2011; 126(4):211-3. PubMed ID: 21934294
    [No Abstract]   [Full Text] [Related]  

  • 10. [The role of anti-neutrophil cytoplasmic antibodies (ANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA) in inflammatory bowel disease].
    Gisbert JP; Gomollón F; Maté J; Pajares JM
    Gastroenterol Hepatol; 2003 May; 26(5):312-24. PubMed ID: 12732107
    [No Abstract]   [Full Text] [Related]  

  • 11. [ANCA vasculitis].
    Bernis C
    Nefrologia; 2003; 23(2):103-6. PubMed ID: 12778872
    [No Abstract]   [Full Text] [Related]  

  • 12. Development and standardization of solid-phase assays for the detection of antineutrophil cytoplasmic antibodies (ANCA) for clinical application: report of a large clinical evaluation study.
    Hagen EC
    Clin Exp Immunol; 1995 Jul; 101 Suppl 1(Suppl 1):29. PubMed ID: 7606857
    [No Abstract]   [Full Text] [Related]  

  • 13. [Vasculitis syndrome. 2: Diagnosis and therapy].
    Kekow J
    MMW Fortschr Med; 2000 Jun; 142(25):45-6. PubMed ID: 10920670
    [No Abstract]   [Full Text] [Related]  

  • 14. [Autoantibodies in clinical practice].
    Terrier B; Mouthon L
    Rev Mal Respir; 2006 Dec; 23(6):743-5. PubMed ID: 17886349
    [No Abstract]   [Full Text] [Related]  

  • 15. Antineutrophil cytoplasmic antibodies as markers for systemic autoimmune disease.
    Homer RJ
    Clin Chest Med; 1998 Dec; 19(4):627-39, viii. PubMed ID: 9917957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor predictive value of antinucleosome and antineutrophil cytoplasmic antibodies in a 270 inception cohort of patients with early naked arthritis of less than one year's duration.
    Berthelot JM; Saraux A; Audrain M; Le Goff P; Hamidou M; Muller JY; Youinou P
    Ann Rheum Dis; 2002 Aug; 61(8):760-1. PubMed ID: 12117694
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical features of bilateral progressive hearing loss associated with myeloperoxidase-antineutrophil cytoplasmic antibody.
    Takagi D; Nakamaru Y; Maguchi S; Furuta Y; Fukuda S
    Ann Otol Rhinol Laryngol; 2004 May; 113(5):388-93. PubMed ID: 15174767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In search of a disease.
    Savino Md G; Campana Md A; Petrone Md G; Grimaldi Md G; Murchison AP
    Surv Ophthalmol; 2017; 62(5):716-721. PubMed ID: 28012876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases.
    Savige J; Dimech W; Fritzler M; Goeken J; Hagen EC; Jennette JC; McEvoy R; Pusey C; Pollock W; Trevisin M; Wiik A; Wong R;
    Am J Clin Pathol; 2003 Sep; 120(3):312-8. PubMed ID: 14502794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there life in the formalin fixed neutrophil for ANCA testing? no!
    Bird AG
    J Clin Pathol; 1999 Jun; 52(6):403-4. PubMed ID: 10562803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.